scholarly article | Q13442814 |
P356 | DOI | 10.1002/JMRI.24897 |
P698 | PubMed publication ID | 25851028 |
P50 | author | Thomas Decaens | Q62096202 |
Alexis Laurent | Q48141150 | ||
P2093 | author name string | Daniel Azoulay | |
Julien Calderaro | |||
Alain Rahmouni | |||
Alain Luciani | |||
Frederic Pigneur | |||
Laurence Baranes | |||
Mélanie Chiaradia | |||
Lambros Tselikas | |||
Ariane Mallat | |||
Elie-Serge Zafrani | |||
Charlotte Costentin | |||
Marion Roux | |||
P2860 | cites work | MRI features of inflammatory hepatocellular adenomas on hepatocyte phase imaging with liver-specific contrast agents. | Q53099955 |
Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. | Q53136942 | ||
Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium. | Q53154992 | ||
Ring-like enhancement of focal nodular hyperplasia with hepatobiliary-phase Gd-EOB-DTPA-enhanced magnetic resonance imaging: radiological-pathological correlation. | Q53196041 | ||
Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. | Q54643529 | ||
Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC | Q57782566 | ||
Hepatobiliary MR imaging with gadolinium-based contrast agents | Q24631773 | ||
Clinical management of benign liver cell tumors | Q33325109 | ||
Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI. | Q33784125 | ||
Imaging of hepatic steatosis | Q34215183 | ||
Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? | Q35594682 | ||
Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis | Q35632208 | ||
Focal nodular hyperplasia | Q36369048 | ||
Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents | Q37945555 | ||
Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis | Q37979150 | ||
Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. | Q38021747 | ||
Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality | Q38063463 | ||
Matched within-patient cohort study of transient arterial phase respiratory motion-related artifact in MR imaging of the liver: gadoxetate disodium versus gadobenate dimeglumine | Q38195093 | ||
Imaging of benign hepatocellular lesions: current concepts and recent updates | Q38196549 | ||
Differentiation of focal nodular hyperplasia from hepatocellular adenomas with low-mechanical-index contrast-enhanced sonography (CEUS): effect of size on diagnostic confidence. | Q38239629 | ||
The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis | Q38299642 | ||
Gadoxetic Acid–enhanced Hepatobiliary Phase MR Imaging: Cellular Insight | Q42853997 | ||
Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers | Q43287335 | ||
Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. | Q43452907 | ||
Focal nodular hyperplasia of the liver: assessment with contrast-enhanced TurboFLASH MR imaging | Q44331220 | ||
Magnetic resonance imaging with hepatospecific contrast agents in cirrhotic rat livers | Q46381565 | ||
Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. | Q46546726 | ||
Hepatic iron and nonalcoholic fatty liver disease. | Q50516617 | ||
Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma. | Q51129770 | ||
Benign liver tumors: differential diagnosis and indications for surgery. | Q52253761 | ||
Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. | Q53032344 | ||
P433 | issue | 5 | |
P921 | main subject | hepatocellular adenoma | Q1172076 |
focal nodular hyperplasia | Q1435219 | ||
P304 | page(s) | 1249-1258 | |
P577 | publication date | 2015-04-06 | |
P1433 | published in | Journal of Magnetic Resonance Imaging | Q15761156 |
P1476 | title | Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI | |
P478 | volume | 42 |
Q48354879 | Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? |
Q49292129 | Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study. |
Q64117986 | Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images |
Q53015861 | Impact of hepatobiliary phase liver MRI versus Contrast-Enhanced Ultrasound after an inconclusive extracellular gadolinium-based contrast-enhanced MRI for the diagnosis of benign hepatocellular tumors. |
Q57301412 | Molecular classification of hepatocellular adenomas: impact on clinical practice |
Q88551246 | Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions |
Search more.